Insulins and analogues - For a Healthy Belgium

Key figures
Data
Graphics
Comments

PRESCRIBERS
Main prescribers: Endocrinology-diabetology	41.28%
INSURED CONSUMERS
% of insured consumers	1.45%
Median age	67 years
Max/min ratio of the median age (by district)	1.11
Percentage of women	46.11%
Ratio Preferential scheme/General scheme	2.23
Coefficient of variation (2022)	11.91
Max/min ratio of % of insured consumers (by district)	1.49
CONSUMPTION
Annual consumption (DDD)	77,536,556
Consumption of DDD (per 100,000 insured persons)	673,709.53
% DDD issued outside the insurance (approximate)	2.32%
Average annual consumption per insured consumer (DDD)	464.10
% of insured consumers with > 3 times the average consumption	2,76%
Coefficient of variation 2013-2015	13.69
Coefficient of variation 2020-2022	15.18
Trend 2013-2022	0.41%
Trend 2013-2019	0.98%
Trend 2019-2022	-0.71%
DIRECT EXPENDITURE (DDD)
Annual expenditure charged to the insurance	84,525,560€
Average annual expenditure per insured person	7.34 €
Average patient share per insured consumer	0.00%
Max/min ratio of expenditure per insured person (by disctrict)	1.75
% “Low-cost” medication	29.74%
Trend 2013-2022	-0.54%
Trend 2019-2022	-3.31%

On this table, when a statistical test has been performed, the data showing a significant difference is displayed on an yellow background, otherwise on a grey background.

+ - ATC codes selected for analysis Click to collapse

CODES (ATC-5)	LABELS
A10AB	INSULINS AND ANALOGUES FOR INJECTION, FAST-ACTING
A10AC	INSULINS AND ANALOGUES FOR INJECTION, INTERMEDIATE-ACTING
A10AD	INSULINS AND ANALOGUES FOR INJECTION, INTERMEDIATE-ACTING COMBINED WITH FAST-ACTING
A10AE	INSULINS AND ANALOGUES FOR INJECTION, LONG-ACTING